newsfilter
← Latest News
PR Newswire·

Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy Training Program; Ready to Start Health Canada Approved Psilocybin Clinical Trial

TORONTO, Nov. 2, 2021 /PRNewswire/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE:BRAX) (OTC:BRAXF) (FWB: 496), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disord